Tilray Pharma has strengthened its European pharmaceutical footprint through a strategic distribution agreement between its subsidiary CC Pharma and UK-based Smartway Pharmaceuticals. The partnership combines Smartway's established national distribution network with CC Pharma's GMP-certified sourcing capabilities and manufacturing expertise to enhance the availability of pharmaceutical products across the United Kingdom.
The collaboration focuses on expanding parallel imports and specialty pharmaceutical supply within the UK market, valued at approximately £1 billion annually. By leveraging complementary operational strengths, the two companies aim to improve product accessibility and supply chain efficiency across healthcare providers in the region.
This agreement represents part of Tilray's broader strategy to consolidate and expand its medical pharmaceutical operations across Europe. The UK distribution network enhancement positions the company to serve growing demand for specialty and generic pharmaceutical products in one of Europe's largest healthcare markets.